Abiopharma

🔍 ROBBINS LARRY (Executive)

Company: Butterfly Network, Inc. (BFLY)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 215,233 shares of Class A Common Stock at $9.5418 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 12,243,530.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 500,000 shares of Class A Common Stock at $9.2355 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 11,743,530.00 | transaction_form_type: 4 | Footnotes: F6, F7, F3
• Sold 175,300 shares of Class A Common Stock at $8.8604 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 4,371,387.00 | transaction_form_type: 4 | Footnotes: F8, F4
• Sold 824,700 shares of Class A Common Stock at $8.6973 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 3,546,687.00 | transaction_form_type: 4 | Footnotes: F9, F4
• Sold 582,500 shares of Class A Common Stock at $8.9702 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 2,964,187.00 | transaction_form_type: 4 | Footnotes: F10, F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | shares_owned_after: 390,952.00

Footnotes:

• F1: These shares of the Issuer's common stock, par value $0.0001 per share (the "Shares"), were sold by Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P.
• F2: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.43 to $9.575, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
• F3: Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.
• F4: Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities.
• F5: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
• F6: These Shares were sold by Glenview Offshore Opportunity Master Fund, Ltd.
• F7: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $9.035 to $9.3408, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
• F8: This price reflects the weighted average price for open-market sales of Shares on August 13, 2026 within a $1.00 range. The actual prices for these transactions range from $8.86 to $9.12, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
• F9: This price reflects the weighted average price for open-market sales of Shares on August 14, 2026 within a $1.00 range. The actual prices for these transactions range from $8.36 to $8.94, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
• F10: This price reflects the weighted average price for open-market sales of Shares on August 17, 2026 within a $1.00 range. The actual prices for these transactions range from $8.85 to $9.07, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.